Searching…
In our industry, impact can and must always be quantified in numbers—and there are plenty of them to be found in this Annual Report. However, the one that stands out most to me in 2021 is not a sales figure or market share.
Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones. The condition is typically diagnosed in adults, but research s...
Johnson & Johnson annual operating expenses for 2022 were $60.631B, a 1.79% increase from 2021.
Johnson & Johnson's operated at median selling and marketing expense of 700 million from fiscal years ending January 2021 to 2024. Looking back at the last 5 years, Johnson & Johnson's selling and marketing expense pe...
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Johnson & Johnson and its subsidiaries (the Company) have approximately 134,500 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field.
Net earnings from continuing operations show a downward trend from 22.26% in 2021 to about 15.84% in 2024, reflecting the combined impact of increased R&D, other expenses, and stable operating margins.
In depth view into Johnson & Johnson Sales and Marketing Expense (Annual Per Share) including historical data from 1990, charts and stats.
Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being.
These items are uncertain, depend on various factors, and could be material to Johnson & Johnson's results computed in accordance with GAAP.
